Trials / Completed
CompletedNCT01841086
Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation
A Randomized, Open-label, Single Dose, 3-Treatment, 3-Period Williams-Design to Assess the Pharmacokinetic Characteristics and Food Effect of Sarpogrelate HCl CR Tablets Compared With Sarpogrelate HCl IR Tablets in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics of sarpogrelate controlled-release formulation (CR) in comparison to immediate-release formulation (IR) and Food effect on the pharmacokinetics of sarpogrelate CR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anplag | Sarpogrelate HCl 300mg once a day or 100mg three times a day |
| DRUG | UI03SPG300CT | Sarpogrelate HCl 300mg once a day or 100mg three times a day |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-12-01
- First posted
- 2013-04-26
- Last updated
- 2013-04-26
Source: ClinicalTrials.gov record NCT01841086. Inclusion in this directory is not an endorsement.